Anupam Rasayan completes Bliss GVS Pharma acquisition
after close1 source ↓written by the desknot a recommendation
- in Bliss GVS
- 48.2% controlling stake
- GVS Pharma
- ₹299 per share
- financed
- ₹300 crore term loan
- from financial investors
- ₹1,450 crore
Anupam Rasayan India has successfully acquired a 48.2% controlling stake in Bliss GVS Pharma at ₹299 per share. This marks its third strategic inorganic transaction, enhancing its portfolio in finished dosage formulations. The deal was financed through a ₹300 crore term loan and ₹1,450 crore from financial investors, including Bain Capital.
This acquisition strengthens Anupam Rasayan's position in the specialty chemicals and pharmaceuticals sectors, potentially boosting market sentiment.
Not investment advice. For informational purposes only.